The FDA-approved Wegovy label, for example, describes semaglutide as a GLP-1 receptor agonist used with reduced calories and increased physical activity for long-term weight reduction in certain adults and adolescents, and for reducing risk of major cardiovascular events in certain adults with cardiovascular disease and overweight or obesity
Its oral formulation, Rybelsus, was approved in 2019 for type 2 diabetes
Are GLP-1 drugs safe long-term
Pre-meal Strategy : Consider having a small protein-rich snack 15-20 minutes before larger meals
Registered dietitians teach practical food skills, meal planning, and strategies for navigating social situations and travel
For those already prone to delayed gastric emptying, Ozempic can exacerbate their condition